PASITHEA THERAPEUTICS CORP. BRIO RETAINER AGREEMENT STOCK OPTION GRANT NOTICEStock Option Grant Notice • September 10th, 2021 • Pasithea Therapeutics Corp. • Pharmaceutical preparations • Delaware
Pasithea Therapeutics Corp., a corporation incorporated under the laws of the State of Delaware (the “Company”), pursuant to the retainer agreement with Brio Financial Group, LLC dated April 13, 2021 (the “Brio Retainer Agreement”), hereby grants to the holder listed below (“Grantee”), an option to purchase the number of shares of the Company’s Common Stock (the “Shares”) set forth below (the “Option”). This Option is subject to all of the terms and conditions set forth herein and in the Stock Option Agreement, attached hereto (the “Stock Option Agreement”), and the Brio Retainer Agreement (a copy of which has been provided to Grantee), both of which are incorporated herein in their entirety. Any capitalized terms not otherwise defined herein shall have the meanings ascribed thereto in the Brio Retainer Agreement or the Grant Notice.
